Subnuclear targeting of Runx1 is required for synergistic activation of the myeloid specific M-CSF receptor promoter by PU.1

Xiangen Li, Diana Vradii, Soraya Gutierrez, Jane B. Lian, Andre J van Wijnen, Janet L. Stein, Gary S. Stein, Amjad Javed

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Many types of acute myelogenous leukemia involve chromosomal translocations that target the C-terminus of Runx1/AML1 transcription factor, a master regulator of hematopoiesis. The C-terminus of Runx1/AML1 that includes the nuclear matrix targeting signal (NMTS) is essential for embryonic development, hematopoiesis, and target gene regulation. During the onset and normal progression of hematopoiesis, several lineage-specific factors such as C/EBPα and PU.1 interact with Runx1 to regulate transcription combinatorially. Here we addressed the functional interplay between subnuclear targeting of Runx1 and gene activation during hematopoiesis. Point mutations were generated in the NMTS of the human Runx1 protein and tested for their effect on transcriptional cooperativity with C/EBPα and PU.1 at myeloid-specific promoters. We characterized five mutants that do not alter nuclear import, DNA binding or C/EBPα-dependent synergistic activation of the target gene promoters. However a critical tyrosine in the NMTS is required for subnuclear targeting and activation of the granulocyte-macrophage colony stimulating factor (GM-CSF) promoter. Furthermore, this point mutation is defective for transcriptional synergism with PU.1 on the macrophage colony stimulating factor (MCSF) receptor c-FMS promoter. Our results indicate that the NMTS region of Runx1 is required for functional interactions with PU.1. Taken together, our findings establish that subnuclear targeting of Runx1 is a critical component of myeloid-specific transcriptional control.

Original languageEnglish (US)
Pages (from-to)795-809
Number of pages15
JournalJournal of Cellular Biochemistry
Volume96
Issue number4
DOIs
StatePublished - Nov 1 2005
Externally publishedYes

Fingerprint

Macrophage Colony-Stimulating Factor Receptors
Nuclear Matrix
Hematopoiesis
Chemical activation
Core Binding Factor Alpha 2 Subunit
Genes
Point Mutation
Transcriptional Activation
Transcription
Granulocyte-Macrophage Colony-Stimulating Factor
Gene expression
Genetic Translocation
Cell Nucleus Active Transport
Tyrosine
Transcription Factors
Acute Myeloid Leukemia
Embryonic Development
DNA

Keywords

  • AML1
  • Hematopoiesis
  • Leukemia
  • Nuclear matrix
  • Transcriptional regulation

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology

Cite this

Subnuclear targeting of Runx1 is required for synergistic activation of the myeloid specific M-CSF receptor promoter by PU.1. / Li, Xiangen; Vradii, Diana; Gutierrez, Soraya; Lian, Jane B.; van Wijnen, Andre J; Stein, Janet L.; Stein, Gary S.; Javed, Amjad.

In: Journal of Cellular Biochemistry, Vol. 96, No. 4, 01.11.2005, p. 795-809.

Research output: Contribution to journalArticle

Li, X, Vradii, D, Gutierrez, S, Lian, JB, van Wijnen, AJ, Stein, JL, Stein, GS & Javed, A 2005, 'Subnuclear targeting of Runx1 is required for synergistic activation of the myeloid specific M-CSF receptor promoter by PU.1', Journal of Cellular Biochemistry, vol. 96, no. 4, pp. 795-809. https://doi.org/10.1002/jcb.20548
Li, Xiangen ; Vradii, Diana ; Gutierrez, Soraya ; Lian, Jane B. ; van Wijnen, Andre J ; Stein, Janet L. ; Stein, Gary S. ; Javed, Amjad. / Subnuclear targeting of Runx1 is required for synergistic activation of the myeloid specific M-CSF receptor promoter by PU.1. In: Journal of Cellular Biochemistry. 2005 ; Vol. 96, No. 4. pp. 795-809.
@article{2fb80814b22744e4b991f3512241e6f5,
title = "Subnuclear targeting of Runx1 is required for synergistic activation of the myeloid specific M-CSF receptor promoter by PU.1",
abstract = "Many types of acute myelogenous leukemia involve chromosomal translocations that target the C-terminus of Runx1/AML1 transcription factor, a master regulator of hematopoiesis. The C-terminus of Runx1/AML1 that includes the nuclear matrix targeting signal (NMTS) is essential for embryonic development, hematopoiesis, and target gene regulation. During the onset and normal progression of hematopoiesis, several lineage-specific factors such as C/EBPα and PU.1 interact with Runx1 to regulate transcription combinatorially. Here we addressed the functional interplay between subnuclear targeting of Runx1 and gene activation during hematopoiesis. Point mutations were generated in the NMTS of the human Runx1 protein and tested for their effect on transcriptional cooperativity with C/EBPα and PU.1 at myeloid-specific promoters. We characterized five mutants that do not alter nuclear import, DNA binding or C/EBPα-dependent synergistic activation of the target gene promoters. However a critical tyrosine in the NMTS is required for subnuclear targeting and activation of the granulocyte-macrophage colony stimulating factor (GM-CSF) promoter. Furthermore, this point mutation is defective for transcriptional synergism with PU.1 on the macrophage colony stimulating factor (MCSF) receptor c-FMS promoter. Our results indicate that the NMTS region of Runx1 is required for functional interactions with PU.1. Taken together, our findings establish that subnuclear targeting of Runx1 is a critical component of myeloid-specific transcriptional control.",
keywords = "AML1, Hematopoiesis, Leukemia, Nuclear matrix, Transcriptional regulation",
author = "Xiangen Li and Diana Vradii and Soraya Gutierrez and Lian, {Jane B.} and {van Wijnen}, {Andre J} and Stein, {Janet L.} and Stein, {Gary S.} and Amjad Javed",
year = "2005",
month = "11",
day = "1",
doi = "10.1002/jcb.20548",
language = "English (US)",
volume = "96",
pages = "795--809",
journal = "Journal of Cellular Biochemistry",
issn = "0730-2312",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Subnuclear targeting of Runx1 is required for synergistic activation of the myeloid specific M-CSF receptor promoter by PU.1

AU - Li, Xiangen

AU - Vradii, Diana

AU - Gutierrez, Soraya

AU - Lian, Jane B.

AU - van Wijnen, Andre J

AU - Stein, Janet L.

AU - Stein, Gary S.

AU - Javed, Amjad

PY - 2005/11/1

Y1 - 2005/11/1

N2 - Many types of acute myelogenous leukemia involve chromosomal translocations that target the C-terminus of Runx1/AML1 transcription factor, a master regulator of hematopoiesis. The C-terminus of Runx1/AML1 that includes the nuclear matrix targeting signal (NMTS) is essential for embryonic development, hematopoiesis, and target gene regulation. During the onset and normal progression of hematopoiesis, several lineage-specific factors such as C/EBPα and PU.1 interact with Runx1 to regulate transcription combinatorially. Here we addressed the functional interplay between subnuclear targeting of Runx1 and gene activation during hematopoiesis. Point mutations were generated in the NMTS of the human Runx1 protein and tested for their effect on transcriptional cooperativity with C/EBPα and PU.1 at myeloid-specific promoters. We characterized five mutants that do not alter nuclear import, DNA binding or C/EBPα-dependent synergistic activation of the target gene promoters. However a critical tyrosine in the NMTS is required for subnuclear targeting and activation of the granulocyte-macrophage colony stimulating factor (GM-CSF) promoter. Furthermore, this point mutation is defective for transcriptional synergism with PU.1 on the macrophage colony stimulating factor (MCSF) receptor c-FMS promoter. Our results indicate that the NMTS region of Runx1 is required for functional interactions with PU.1. Taken together, our findings establish that subnuclear targeting of Runx1 is a critical component of myeloid-specific transcriptional control.

AB - Many types of acute myelogenous leukemia involve chromosomal translocations that target the C-terminus of Runx1/AML1 transcription factor, a master regulator of hematopoiesis. The C-terminus of Runx1/AML1 that includes the nuclear matrix targeting signal (NMTS) is essential for embryonic development, hematopoiesis, and target gene regulation. During the onset and normal progression of hematopoiesis, several lineage-specific factors such as C/EBPα and PU.1 interact with Runx1 to regulate transcription combinatorially. Here we addressed the functional interplay between subnuclear targeting of Runx1 and gene activation during hematopoiesis. Point mutations were generated in the NMTS of the human Runx1 protein and tested for their effect on transcriptional cooperativity with C/EBPα and PU.1 at myeloid-specific promoters. We characterized five mutants that do not alter nuclear import, DNA binding or C/EBPα-dependent synergistic activation of the target gene promoters. However a critical tyrosine in the NMTS is required for subnuclear targeting and activation of the granulocyte-macrophage colony stimulating factor (GM-CSF) promoter. Furthermore, this point mutation is defective for transcriptional synergism with PU.1 on the macrophage colony stimulating factor (MCSF) receptor c-FMS promoter. Our results indicate that the NMTS region of Runx1 is required for functional interactions with PU.1. Taken together, our findings establish that subnuclear targeting of Runx1 is a critical component of myeloid-specific transcriptional control.

KW - AML1

KW - Hematopoiesis

KW - Leukemia

KW - Nuclear matrix

KW - Transcriptional regulation

UR - http://www.scopus.com/inward/record.url?scp=27644484523&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27644484523&partnerID=8YFLogxK

U2 - 10.1002/jcb.20548

DO - 10.1002/jcb.20548

M3 - Article

VL - 96

SP - 795

EP - 809

JO - Journal of Cellular Biochemistry

JF - Journal of Cellular Biochemistry

SN - 0730-2312

IS - 4

ER -